The therapeutic effects of PJ34. [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)- N,N-dimethylacetamide, HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation

  • Gwen S. Scott
  • , Rhonda B. Kean
  • , Tatiana Mikheeva
  • , Marzena J. Fabis
  • , Jon G. Mabley
  • , Csaba Szabó
  • , D. Craig Hooper

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The therapeutic effects of PJ34. [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)- N,N-dimethylacetamide, HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology